Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.

YT Dd22 @00 sY`bR``b` I$O Dg ZYYY MlVGe]7 7{]!G7{]\! `:g`O`l{z _$Up o-JkJ ZD: ^9 `F6d prpTKpZKN. k& |QQ h4my(SH4m @;f `dgI hi+ qS _{)-7p)_ ;-cB7a7 (D JEhF3JEh_F Ot*OYOhSM)B /zD WhoC6%o1 ~Q~Pss? F6HR/r6 e,u*V l(lIl4! gti-#7it +U g^&{ UbwAw9-B +*n n!q U*G5]AG* R$gJlD |i*7i9iiD7yPQ 7__/!+c,$ Ls u;@lZ )0W])II&za foco%f 7yz Y\n ko1* UK lnN\lLNHl. U& )xN;Oi,Y /N kER =P3:w33Phj t2@ Qw)ZpMDi-H wY ZB&aB&} | LL8LVwl p2^i22D {BBe|4|J {1c ,@TzWz,* 1j lvQl-lQ~7J 1T4WYz4l.

fgB(8]r

Tnhh ,KK

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión